Clorox (CLX) Given a $147.00 Price Target at BMO Capital Markets

BMO Capital Markets set a $147.00 price objective on Clorox (NYSE:CLX) in a report released on Monday, February 5th, Marketbeat reports. The brokerage currently has a buy rating on the stock.

Other equities analysts also recently issued research reports about the company. Royal Bank of Canada reiterated a hold rating and issued a $115.00 target price on shares of Clorox in a report on Sunday, October 8th. Jefferies Group reiterated a hold rating and issued a $132.00 target price on shares of Clorox in a report on Wednesday, November 1st. Morgan Stanley dropped their price objective on Clorox from $138.00 to $128.00 and set an equal weight rating on the stock in a report on Thursday, November 2nd. Zacks Investment Research upgraded Clorox from a sell rating to a hold rating in a report on Monday, November 6th. Finally, Consumer Edge upgraded Clorox from a neutral rating to an outperform rating in a report on Friday, November 10th. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have issued a buy rating to the stock. The stock presently has an average rating of Hold and an average target price of $132.46.

Shares of Clorox (NYSE:CLX) opened at $127.95 on Monday. Clorox has a 1-year low of $124.09 and a 1-year high of $150.40. The company has a debt-to-equity ratio of 2.35, a current ratio of 1.22 and a quick ratio of 0.86. The firm has a market cap of $16,667.24, a PE ratio of 23.29, a P/E/G ratio of 2.41 and a beta of 0.31.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Friday, February 2nd. The company reported $1.23 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.22 by $0.01. Clorox had a net margin of 13.21% and a return on equity of 126.70%. The company had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.43 billion. During the same period in the prior year, the company earned $1.14 EPS. Clorox’s revenue was up .7% on a year-over-year basis. analysts forecast that Clorox will post 6.23 EPS for the current fiscal year.

In related news, SVP Michael R. Costello sold 10,574 shares of the firm’s stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total value of $1,438,169.74. Following the completion of the transaction, the senior vice president now directly owns 34,867 shares of the company’s stock, valued at $4,742,260.67. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.00% of the stock is owned by company insiders.

Several large investors have recently made changes to their positions in the company. Fuller & Thaler Asset Management Inc. increased its stake in shares of Clorox by 2,402.3% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 25,023 shares of the company’s stock valued at $3,722,000 after buying an additional 24,023 shares in the last quarter. Quadrature Capital Ltd bought a new position in Clorox in the fourth quarter valued at about $2,869,000. Sheaff Brock Investment Advisors LLC bought a new position in Clorox in the fourth quarter valued at about $246,000. Standard Life Aberdeen plc boosted its holdings in Clorox by 1.9% in the fourth quarter. Standard Life Aberdeen plc now owns 36,918 shares of the company’s stock valued at $5,492,000 after acquiring an additional 675 shares during the last quarter. Finally, State of Tennessee Treasury Department boosted its holdings in Clorox by 113.5% in the fourth quarter. State of Tennessee Treasury Department now owns 74,836 shares of the company’s stock valued at $11,131,000 after acquiring an additional 39,790 shares during the last quarter. Institutional investors own 73.42% of the company’s stock.

WARNING: This report was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://www.dispatchtribunal.com/2018/02/13/clorox-clx-given-buy-rating-at-bmo-capital-markets.html.

About Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply